Stocktoria
BridgeBio Pharma, Inc. BBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-06-27
BridgeBio Pharma, Inc. statistics & valuation
Market cap$13.8B
P / S27.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -104.2% | -267.2% | -6528.8% | -659.6% | -827.1% |
| FCF margin | -89.0% | -235.1% | -5686.6% | -546.5% | -733.2% |
| Debt / equity | -0.96× | -0.30× | -0.33× | -0.34× | -0.49× |
| Current ratio | 2.77 | 4.67 | 3.32 | 4.52 | 6.58 |
| Revenue growth | 126.3% | 2285.3% | -88.0% | 11.4% | 745.1% |
Source: SEC EDGAR filings · CIK 0001743881 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.